Capital Research Global Investors’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02B Buy
2,279,877
+216,999
+11% +$102M 0.14% 111
2026
Q1
$818M Buy
2,062,878
+167,923
+9% +$75.9M 0.13% 133
2025
Q4
$890M Sell
1,894,955
-629,557
-25% -$280M 0.16% 114
2025
Q3
$1.25B Buy
2,524,512
+1,751,432
+227% +$990M 0.23% 96
2025
Q2
$396M Buy
773,080
+98,819
+15% +$46M 0.08% 159
2025
Q1
$289M Buy
674,261
+180,063
+36% +$87.5M 0.06% 176
2024
Q4
$240M Buy
+494,198
New +$258M 0.05% 206

Other funds holding SNPS

Capital Research Global Investors's SNPS Position: Q2 2026 in Review

Capital Research Global Investors increased its Synopsys (SNPS) stake by 11% in Q2 2026, buying an estimated $102M and bringing the position to 2,279,877 shares worth $1.02B. The position accounts for 0.14% of the portfolio, ranked #111.

Capital Research Global Investors first reported a position in SNPS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.25B in Q3 2025. 1,108 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Capital Research Global Investors held 2,279,877 shares of Synopsys worth $1.02B as of Q2 2026.
  • Capital Research Global Investors bought 216,999 Synopsys shares in Q2 2026, an estimated $102M.
  • Synopsys made up 0.14% of Capital Research Global Investors's portfolio in Q2 2026, its #111 holding.
  • Capital Research Global Investors first reported a position in Synopsys in Q4 2024 and has held it in 7 quarters since.
  • Capital Research Global Investors's Synopsys position peaked at $1.25B in Q3 2025.
  • 1,108 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Capital Research Global Investors's 13F filing for Q2 2026, filed 12 Aug 2026.